Delivery Order SPE2DB22D3004-SPE2DB25FPH60

Award Date 1/30/25
Potential Completion Date 1/31/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,676.79 firm fixed-price delivery order contract is for the supply of 4567118192 BELSOMRA 20 MG TABLET 30S to support federal healthcare programs. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This contract award, with ID SPE2DX15D1053|SPE2DX25F6GEL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,017.22 firm fixed-price delivery order is for the supply of BELSOMRA 20 MG TABLET 30S, a prescription medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a $1,844.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of BELSOMRA 5 MG TABLET 30S, a pharmaceutical product, to support federal healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Firm Fixed Price Delivery Order valued at $1,527.84 for the supply of 4565333163 - BELSOMRA 20 MG TABLET 30S. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical on August 2, 2024 and has an ultimate completion date of August 5, 2024. This contract is not a set-aside. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,132.22, is for the supply of BELSOMRA 10 MG TABLET 30S, a prescription sleep medication. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,742.16 firm-fixed-price delivery order is for Belsomra 20 mg tablets, a medication used to treat insomnia. The contract has an ultimate completion date of February 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Belsomra 20 mg tablets. The contract has a firm fixed price of $2,567.05 and a completion date of June 25, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. The IDC enables DLA to efficiently...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The order is for the supply of 4564133859 BELSOMRA 10 MG TABLET 30S, a brand name pharmaceutical product. The ceiling value of the order is $1,533.90 and the period of performance extends through April 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,031,417 tablets of the medication BELSOMRA 20 MG. The contract, valued at $1,339.92, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. There is no set-aside designation for this contract. Amerisourcebergen, one of the largest pharmaceutical distribution companies, holds a large Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office division, a major pharmaceutical distributor. The $1,774.14 firm fixed-price contract is for the supply of the prescription drug BELSOMRA 20 MG TABLET 30S. The contract has an ultimate completion date of October 15, 2024. AmerisourceBergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by the DLA and other agencies to provide a wide range...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPH60
    Delivery Order

This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPH60, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,002.26 firm fixed-price delivery order contract is for the provision of the medication BELSOMRA 20 MG TABLET 30S, with a period of performance ending on January 31, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract awarded in this case is a delivery order off of that larger IDC contract.

Generated 5/1/25, 10:21 AM